Senior citizens are the latest group of Americans to face steep increases in their health insurance premiums for 2026.
When the sole manufacturer withdrew a critical cancer drug from Medicare and Medicaid, patients were left without options.
Our analysis shows that the introduction of a POH could negatively impact the financial health of existing SCHs by siphoning profitable service types and reducing their proportion of healthier, ...
About 300,000 enrollees will transition to Medica, setting the stage for closure of 40-year-old nonprofit UCare.
In support of its efforts to make care more affordable, a detailed review of statewide health care spending data led Oregon ...
The cost for Medicare Part B premiums will rise about 10% in 2026, wiping away about one-third of the Social Security cost-of-living increase for the average beneficiary.
VRA Enterprises LLC, doing business as a Tampa pharmacy called Precision RX, settled allegations it fraudulently billed ...
Median net sales for the 19 drugs in 2022 were $1.97 billion (range, $988 million-$8.36 billion). The drugs with the highest net sales were lenalidomide (Revlimid; $8.36 billion), ...
On this Plain Talk, a longtime North Dakota health care executive says a single-payer system for health insurance is ...
On Thursday, November 6, the Centers for Medicare & Medicaid Services (CMS) announced a new drug payment model aimed at ...
Pennsylvania - Real Property - - Pennsylvania Court of Common Pleas, Cumberland County - 2025-10574 - US Bank Trust Company National Association AS Trustee For Velocity Commercial Capital Loan Trust ...
Social Security recipients will see a 2.8% benefit increase in 2026, adding an average of $56 to monthly checks. However, Medicare Part B premium increases may significantly reduce the actual gain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback